Coronary artery spasm – one medical entity with different treatment options
Abstract
Abstract
Introduction. Myocardial infarction (MI) is characterized by a critical myocardial ischemia followed by an irreversible myocardial cell damage or death. Case report. We presented two similar clinical cases with the ST segment elevation myocardial infarction (STEMI) diagnosis due to a prolonged coronary artery spasm, but with different treatment options due to different basic patophysiological supstrates and clinical presentations. Conclusion. Coronary artery spasm is a very complex pathophysiological entity with a different medication therapy management. Although the percutaneous coronary intervention can be the first choice, the treatment strategy should be carefully planned.
References
REFERENCES
Thygesen K, Alpert JS, White HD. Universal Definition of Myo-cardial Infarction. J Am Coll Cardiol 2007; 50(22): 2173‒95.
Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome. The CASPAR (Coronary Ar¬tery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 2008; 52(7): 523‒7.
Lanza GA, Carreri G, Crea F. Mechanisms of Coronary Ar¬tery Spasm. Circulation 2011; 124(16): 1774‒82.
Wang LX, Lü SZ, Zhang WJ, Song XT, Chen H, Zhang LJ. Cor-onary spasm, a pathogenic trigger of vulnerable plaque rup-ture. Chin Med J 2011; 124(23): 4071‒8.
Steg G, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569‒619.
Giacoppo D, Baber U, Mehran R. Current developments in dual antiplatelet therapy after stenting. Minerva Cardioan¬giologica 2014; 62(3): 261‒76.
Kaneda H, Taguchi J, Kuwada Y, Hangaishi, Aizawa T, Ya¬makado M, et al. Coronary artery spasm and the polymor¬phisms of the endothelial nitric oxide synthase gene. Circ J 2006; 70(4): 409–13.
Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fu-kata Y, et al. Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary ar¬tery spasm in a por-cine model with interleukin-1beta. Cir¬culation 2000; 101(11): 1319–23.
Otsuka F, Sakakura S, Virmani R. Are mast cells the real cul-prit in atherosclerosis? Eur Heart J 2013; 34(48): 3681‒3.
Zdravkovic V, Pantovic S, Rosic G, Tomic Lucic A, Zdravk¬ovic N, Colic M, et al. Histamine Blood Concentration in Ischemic Heart Disease Patients. J Biomed Biotechnol 2011; 2011: 315709.
Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000; 118(6): 1690‒5.